Menstrual migraine (MM) has a prevalence in the general population of approximately 7%, although it seems to be much higher within the population of females with migraine. Episodes of MM have been reported to be longer, more intense, more disabling, less responsive to acute therapy and more prone to recurrence than those of other types of migraine. MM is demonstrated to have a bi-directional link to affective illnesses such as premenstrual dysphoric disorder and depression. There is clinical and pathophysiological evidence suggesting that the relationship between MM and affective disorders could be linked to ovarian hormones. The aim of this review is to analyze treatment strategies in patients with co-existent MM and affective disorders.
Treatment of menstrual migraine. utility of control of related mood disturbances / Negro, Andrea; Flavia, Napoletano; Luana, Lionetto; Francesco, Marsibilio; Sani, Gabriele; Paolo, Girardi; Martelletti, Paolo. - In: EXPERT REVIEW NEUROTHERAPEUTICS. - ISSN 1744-8360. - ELETTRONICO. - 14:5(2014), pp. 1-10. [10.1586/14737175.2014.906304]
Treatment of menstrual migraine. utility of control of related mood disturbances
NEGRO, ANDREAPrimo
Writing – Original Draft Preparation
;Flavia Napoletano;SANI, Gabriele;MARTELLETTI, Paolo
2014
Abstract
Menstrual migraine (MM) has a prevalence in the general population of approximately 7%, although it seems to be much higher within the population of females with migraine. Episodes of MM have been reported to be longer, more intense, more disabling, less responsive to acute therapy and more prone to recurrence than those of other types of migraine. MM is demonstrated to have a bi-directional link to affective illnesses such as premenstrual dysphoric disorder and depression. There is clinical and pathophysiological evidence suggesting that the relationship between MM and affective disorders could be linked to ovarian hormones. The aim of this review is to analyze treatment strategies in patients with co-existent MM and affective disorders.File | Dimensione | Formato | |
---|---|---|---|
Negro_Treatment_2014.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
321.47 kB
Formato
Adobe PDF
|
321.47 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.